Bluejay Diagnostics, Inc.

US$2.35As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BJDXHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (91.12%)
Div yield —
ROE (98.89%)
Medical Devices
Beta (5Y) 0.92
PE TTM —
TSR TTM (92.54%)
Mkt cap US$2.625M
ROIC (61.24%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.01
28.26%
(63.00%)
Sell 1|0|1|9|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.03
4.18%
4.35%
1.70%
4.51%
Revenue$M
0.159
0.162
0.157
0.155
3.82%
3.62%
2.51%
(0.22%)
Peers (US$2.625M)
Cap (US$)
PE
2.782M
—
Capital
TTM
5Y
10Y
Leveragex
0.983
0.780
0.644
EBIT/Intx
1.808
3.335
2.862
Own earn%
(17.55)
(50.16)
(50.17)
Sh yield%
33.94
42.94
44.81
Owners
Insiders/Inst%
1.10
70.21
Short interest%
2.09
SBC / revenue%
4.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
8–14
$1 testx
—
Incr. ROIC%
1